Make us your home page

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

Alzheimer's study points to possible benefit of caffeine, USF scientists say

TAMPA — Hefty jolts of caffeine have reinvigorated the brains of old, demented mice at the University of South Florida.

Mice aren't humans. And caffeine jitters aren't for the faint of heart. But the caffeine connection raises intriguing possibilities for treating Alzheimer's disease.

USF scientists "were able to look both at the idea of treatment — giving caffeine to animals that have already developed pathology — as well as prevention,'' said Neil Buckholtz, chief of the dementias of aging branch of the National Institute on Aging. "It's really interesting.''

So should you binge on latte or invest in Starbucks?

No way, Buckholtz and others cautioned.

"Lots of things have proven effective in mouse models but very few have been tested in humans,'' he said. "That's the gold standard, to see how this translates to humans.''

The caffeine study, described in today's online version of the Journal of Alzheimer's Disease, was performed on mice genetically engineered to develop high levels of beta-amyloid, a protein associated with Alzheimer's in human brains.

Such mice typically start showing cognitive decline and elevated beta-amyloid levels by 8 or 9 months of age. As they grow older, they also develop sticky clumps of amyloid plaque in their brains, another sign of human Alzheimer's.

Three years ago, the USF group showed that putting the mice on a high-caffeine diet soon after birth seems to prevent or delay these symptoms.

The latest experiments were aimed at treatment.

The mice received no caffeine until they were 18 to 19 months old, the human equivalent of about 70.

By then, the mice had progressed well into their dementia. Beta-amyloid levels were high, protein clumps had developed in their brains, and they performed poorly on memory tests.

For four or five weeks, some of the mice received pure caffeine in their drinking water, equivalent to 500 milligrams a day in an average human. That's what you would get in about five 8-ounce cups of regular coffee or 14 12-ounce cans of Coke Classic.

Control mice drank straight water.

Then all the mice went swimming.

Many bad turns

In water mazes, mice swim around until they discover a comforting underwater platform that allows them to stand up and rest. Researchers return them to the water and watch how quickly they navigate their way back to the platform.

Normal mice with good memories find the platform without too many bad turns. A demented mouse struggles to learn.

In the USF study, demented mice fed straight water took more than twice as many bad turns as normal mice did.

But the demented mice fed caffeine found the platforms about as well as the normal mice.

Furthermore, their brains contained fewer plaques and lower beta-amyloid levels than the brains of mice that drank straight water.

"There were rather striking benefits'' of caffeine, said Dr. Gary Arendash of USF's Florida Alzheimer's Disease Research Center and lead author on the journal article. "There was reversal of memory impairment in mice, which leads us to believe that caffeine could be a very attractive treatment for the disease.''

Caffeine did not improve the performance of normal mice, ruling out the possibility that extra adrenaline led to better scores.

A complex disease

William Thies, chief medical officer for the Alzheimer's Association, called the study interesting but noted that other substances have reduced beta-amyloid and improved cognition in mice, but have flopped in humans.

Human Alzheimer's is a complex constellation of symptoms and events that destroy brain cells. Scientists are far from understanding how these factors interrelate.

Arendash acknowledges the limitations of mouse studies and wants to move quickly into human clinical trials on caffeine. He notes that a recent Finnish epidemiological study indicated that people with Alzheimer's drank less coffee over the course of their lives than people of similar ages who did not have Alzheimer's.

People with Parkinson's disease and Type II diabetes also reported less coffee consumption than healthy people of similar ages.

Such backward-looking surveys have limited use. People often underestimate or exaggerate their lifestyle choices. And maybe coffee drinkers exercised more, ate their veggies or had other habits that explain any health differences later in life.

"We are not saying this is the silver bullet,'' Arendash said. "But there is something about this compound that has benefits for aging bodies.''

Hurdles remain

The true test would be human clinical trials, but caffeine would face several hurdles.

Even a small, pilot trial can cost hundreds of thousands of dollars, Arendash said.

Caffeine can't be patented, so the drug manufacturers that bankroll most Alzheimer's trials are unlikely to show interest.

Caffeine would have one advantage when it comes to human trials, Thies said.

"It has a very long safety history and is broadly distributed in the population,'' he said. "You have a much less chance of hurting anybody.''

Stephen Nohlgren can be reached at (727) 893-8442 or

Should I drink more coffee?

Not without talking to your doctor. The mice were given doses of caffeine that, if adjusted for the average human, would be equal to 500 milligrams. That could harm people with heart disease or other conditions. Other substances that have tested well in mice have failed to help humans. The caffeine study "really shows genuine value,'' said David Morgan, a USF professor and researcher on Alzheimer's. "But the thought of uncontrolled use of these things sends shudders down my spine, that people will read this and jump to conclusions that may be misplaced.''

How much is 500 mg of caffeine?

It's about five 8-oz cups of home-brewed coffee, but of course caffeine is available in many items:

Espresso, 1 fluid oz: 64 mg

Instant coffee, regular, 8 oz: 62 mg

Brewed coffee, 8 oz: 95 mg

Starbucks Coffee Grande, 16 oz: 330 mg

Black tea, brewed, 8 oz: 47 mg

Snapple Iced Tea, 16 oz: 18 mg

Sobe Green Tea, 8 oz: 14 mg

Coca-Cola Classic, 12 oz: 35 mg

Diet Coke, 12 oz: 47 mg

Mountain Dew, Diet Mountain Dew, 12 oz: 54 mg

Red Bull, 8.3 oz: 76 mg

Excedrin Extra Strength, 2 tablets: 130 mg

NoDoz Maximum Strength, 1 tablet: 200 mg

Alzheimer's study points to possible benefit of caffeine, USF scientists say 07/05/09 [Last modified: Tuesday, July 14, 2009 4:22pm]
Photo reprints | Article reprints

© 2017 Tampa Bay Times


Join the discussion: Click to view comments, add yours

  1. No. 21 USF Bulls roll over Temple to stay undefeated


    TAMPA — They emerged from Raymond James Stadium's southwest tunnel on the 11-month anniversary of their public humiliation at Temple.

    Bulls tailback Darius Tice, who rushes for 117 yards, is elated by his 47-yard run for a touchdown in the second quarter for a 10-0 lead.
  2. Fennelly: USF thrashes Temple to stay unbeaten; too bad not many saw it in person



    No. 21 USF ran its record to 4-0 Thursday night with some payback against Temple, a 43-7 trouncing, no contest, as if anyone cares, at least judging by the paltry crowd at Raymond James Stadium. Where was everybody?

    Bulls cornerback Deatrick Nichols (3) celebrates with teammates after making a defensive play during the first half.
  3. Former Ray Tim Beckham's over being traded, or is he?

    The Heater

    BALTIMORE — As the Rays reunited Thursday with Tim Beckham for the first time since he was dealt July 31 to Baltimore, it became very clear that not everything in assessing the trade is as it appears.

    Tim Beckham, here in action Monday against the Red Sox, has hit .310, with 10 homers and 26 RBIs since going to the Orioles.
  4. Bucs probe how to fix deep-ball chances missed vs. Bears


    TAMPA — It was only minutes after the Bucs had demolished the Bears 29-7 Sunday when quarterback Jameis Winston tried one final time to connect with receiver DeSean Jackson.

    QB Jameis Winston says he’s focused on the deep-ball chances to DeSean Jackson he missed in the opener: “We left a lot out there.”
  5. Rays journal: Ugly first inning dooms Andriese, Rays against Orioles (w/video)

    The Heater

    BALTIMORE — Rays manager Kevin Cash said before Thursday's game that RHP Matt Andriese was among the pitchers who would most benefit from a strong finish to the season.

    Matt Andriese has a tough first: hits to four of first five batters, leading to three runs, the only ones he gives up in six innings